Announcements Trials
Browse Landscape

Phase

Phase NA 92Phase 1 6Phase 3 5Phase 2 5Phase EARLY_PHASE1 4Phase 2/3 4Phase 1/2 4Phase 4 3

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other 1Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 699Breast Neoplasms 629Neoplasms 582Leukemia, Myeloid, Acute 481Colorectal Neoplasms 455Multiple Myeloma 444Melanoma 424Prostatic Neoplasms 383Neoplasm Metastasis 370Pancreatic Neoplasms 361Recurrence 347Lymphoma 340Ovarian Neoplasms 322Lung Neoplasms 297Lymphoma, Non-Hodgkin 295Leukemia 287Glioblastoma 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Stomach Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 235Carcinoma, Hepatocellular 231Squamous Cell Carcinoma of Head and Neck 219Lymphoma, Large B-Cell, Diffuse 217Myelodysplastic Syndromes 212Carcinoma, Renal Cell 210Lymphoma, Follicular 183Head and Neck Neoplasms 172Brain Neoplasms 169Triple Negative Breast Neoplasms 167Lymphoma, Mantle-Cell 167

Interventions

otelixizumab 1Therapeutics 1Secretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Diabetes Mellitus × Clear all
NCT03443635 2022-04-29

CHOP

Tulane University

Phase 1/2 Completed
7,192 enrolled 7 charts
Other

Cardiovascular Diseases, Depression, Diabetes Mellitus, Hypertension, Motor Activity, Neoplasms, Nutrition Disorders, Obesity

NCT04834089 2021-04-08

SOROCOV

Butantan Institute

Phase 1/2 Unknown
618 enrolled
Genitourinary

COVID-19, Cardiovascular Diseases, Diabetes Mellitus, Kidney Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT02000817 2019-06-24

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

GlaxoSmithKline

Phase 1/2 Completed
30 enrolled 21 charts

Cytokine Release Syndrome, Diabetes Mellitus, Diabetes Mellitus, Type 1, Epstein-Barr Virus Infections

NCT00587132 2013-06-24

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

Mayo Clinic

Phase 1/2 Terminated
4 enrolled 2 charts
Gastrointestinal

Diabetes Mellitus, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡